Antipodes Partners’s Tellurian Inc. TELL Stock Holding History

Antipodes Partners’s Portfolio TELL Stock Details TELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,864	Closed	-$6K	–	81
2022 Q4	$6K	Buy	+3,864	New	+$9.68K	﹤0.01%	69

Other funds holding TELL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Antipodes Partners's TELL Position: Q1 2023 in Review

Antipodes Partners sold out of Tellurian Inc. (TELL) in Q1 2023, closing a stake of 3,864 shares — an estimated $6K sold.

Antipodes Partners first reported a position in TELL in Q4 2022 and held it in 1 quarter. The position peaked at $6K in Q4 2022. 230 funds tracked by Wall St. Rank hold TELL as of Q1 2023.

Antipodes Partners reported no remaining Tellurian Inc. position as of Q1 2023 after selling out during the quarter.
Antipodes Partners sold 3,864 Tellurian Inc. shares in Q1 2023, an estimated $6K.
Antipodes Partners first reported a position in Tellurian Inc. in Q4 2022 and held it in 1 quarter.
Antipodes Partners's Tellurian Inc. position peaked at $6K in Q4 2022.
230 funds tracked by Wall St. Rank held Tellurian Inc. as of Q1 2023.

Based on Antipodes Partners's 13F filing for Q1 2023, filed 11 May 2023.